TAVQIRI Trademark

Trademark Overview


On Thursday, June 2, 2022, a trademark application was filed for TAVQIRI with the United States Patent and Trademark Office. The USPTO has given the TAVQIRI trademark a serial number of 97439443. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, December 19, 2024. This trademark is owned by Actinium Pharmaceuticals, Inc.. The TAVQIRI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in a preparatory regime for bone marrow transplantation; pharmaceutical preparations for depleting cells expressing CD45 antigen; radiopharmaceutical antibody preparations
tavqiri

General Information


Serial Number97439443
Word MarkTAVQIRI
Filing DateThursday, June 2, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, December 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 15, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for use in oncology; pharmaceutical preparations for use in a preparatory regime for bone marrow transplantation; pharmaceutical preparations for depleting cells expressing CD45 antigen; radiopharmaceutical antibody preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 9, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameActinium Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NameActinium Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Trademark Events


Event DateEvent Description
Monday, June 6, 2022NEW APPLICATION ENTERED
Friday, October 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, June 9, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 5, 2022ASSIGNED TO EXAMINER
Wednesday, October 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 15, 2022PUBLISHED FOR OPPOSITION
Friday, July 7, 2023SOU EXTENSION 1 GRANTED
Tuesday, January 10, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, July 7, 2023SOU TEAS EXTENSION RECEIVED
Friday, July 7, 2023SOU EXTENSION 1 FILED
Tuesday, December 5, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 5, 2023SOU EXTENSION 2 FILED
Tuesday, December 5, 2023SOU EXTENSION 2 GRANTED
Monday, April 29, 2024SOU TEAS EXTENSION RECEIVED
Monday, April 29, 2024SOU EXTENSION 3 FILED
Tuesday, July 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 29, 2024SOU EXTENSION 3 GRANTED
Thursday, December 19, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, April 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 19, 2024SOU EXTENSION 4 FILED
Thursday, December 19, 2024SOU EXTENSION 4 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 8, 2025SOU TEAS EXTENSION RECEIVED